Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
TempraMed Technologies Ltd. ( (TSE:VIVI) ) just unveiled an announcement.
TempraMed Technologies has begun shipping its VIVI-branded temperature-protection devices to pharmacies operated by Maccabi Healthcare Services across Israel and has launched a national in-pharmacy and online marketing campaign within this network. As Maccabi serves more than 2.8 million insured members, the rollout marks TempraMed’s first broad brick-and-mortar retail deployment, significantly expanding patient access at the point of care and underscoring the company’s ability to execute at scale within a large healthcare system, which management views as a key step toward recurring demand, stronger brand presence, and further expansion into additional institutional healthcare channels.
More about TempraMed Technologies Ltd.
TempraMed Technologies Ltd. is a global medical device company specializing in temperature-controlled medication storage solutions for life-saving, temperature-sensitive drugs such as insulin and epinephrine. The company develops patented, FDA-registered thermal insulation devices that operate without batteries or external power, including products like VIVI Cap, VIVI Cap Smart, VIVI Epi, and VIVI Med, and markets them across North America, Europe, and Asia to support medication protection and adherence for patients and healthcare providers.
Average Trading Volume: 52,360
Current Market Cap: C$86.65M
Learn more about VIVI stock on TipRanks’ Stock Analysis page.